Nifty Pharma Rises 0.22% vs Nifty’s 1.1% Fall; Torrent, Natco, Morepen Lead Gains

Pharmaceutical stocks traded firmly on Tuesday even as the broader market declined. The Nifty Pharma index was up 0.22% in the afternoon, making it the best-performing sectoral index of the day. In contrast, the Nifty 50 was down 1.1%.

Over the past month, the pharma index has gained 4%, compared to a 1% rise in the benchmark index.

Torrent Pharma Hits New High

Torrent Pharmaceuticals Ltd touched a new 52-week high of ₹4,423, rising around 3% during the day. The stock has gained 5% in the last four trading sessions and 13% over the past month.

The company expects its India business to continue growing faster than the overall market. Management plans to improve market share in key therapies, increase field force productivity, and scale up the Curatio business.

Torrent recently completed the acquisition of a 48.8% stake in JB Chemicals & Pharmaceuticals. The company is also seeing:

• Strong growth in Brazil
• Gradual improvement in the US business
• Temporary supply challenges in Germany

Natco Pharma Surges on Heavy Volumes

Natco Pharma Ltd jumped up to 6% to ₹947.50, supported by a sharp rise in trading volumes. About 7.66 million shares were traded across exchanges. The stock is up 16% in the past month.

Natco plans to launch generic semaglutide in India in FY27, which could boost domestic growth to around 20%. The company has maintained its FY26 revenue guidance of ₹4,000 - 4,100 crore and profit guidance of ₹1,280 - 1,300 crore.

After the Adcock deal, Natco has a strong net cash position of ₹2,500 crore, which may be used for future acquisitions.

Morepen Labs Extends Rally

Morepen Laboratories Ltd rose 8% during the day and has gained 24% in just two sessions.

The rally followed news that the company secured a multi-year CDMO contract worth around ₹825 crore from a global pharmaceutical company. Commercial supplies are expected to begin in the next 4–5 months, subject to regulatory approvals.

Read More: NSE Unveils Nanosecond Trading Speeds, Aiming for 100 Million Trades Per Second.

Conclusion

Pharma stocks are attracting strong investor interest despite weakness in the broader market. Gains in Torrent, Natco, and Morepen were supported by positive business updates, acquisitions, and heavy trading volumes. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.